146 related articles for article (PubMed ID: 17540969)
41. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.
D'Amelio M; Terruso V; Famoso G; Di Benedetto N; Realmuto S; Valentino F; Ragonese P; Savettieri G; Aridon P
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):649-54. PubMed ID: 23834850
[TBL] [Abstract][Full Text] [Related]
42. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Kumar G; Goyal MK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
[TBL] [Abstract][Full Text] [Related]
43. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
44. Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial.
Martí-Fàbregas J; Cocho D; Martí-Vilalta JL; Gich I; Belvís R; Bravo Y; Millán M; Castellanos M; Rodríguez-Campello A; Egido J; Geffner D; Gil-Núñez A; Marta J; Navarro R; Obach V; Palomeras E
Cerebrovasc Dis; 2006; 22(2-3):162-9. PubMed ID: 16710082
[TBL] [Abstract][Full Text] [Related]
45. The Warfarin-Aspirin Symptomatic Intracranial Disease Study.
Chimowitz MI; Kokkinos J; Strong J; Brown MB; Levine SR; Silliman S; Pessin MS; Weichel E; Sila CA; Furlan AJ
Neurology; 1995 Aug; 45(8):1488-93. PubMed ID: 7644046
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Vinereanu D; Stevens SR; Alexander JH; Al-Khatib SM; Avezum A; Bahit MC; Granger CB; Lopes RD; Halvorsen S; Hanna M; Husted S; Hylek EM; Mărgulescu AD; Wallentin L; Atar D
Eur Heart J; 2015 Dec; 36(46):3268-75. PubMed ID: 26371113
[TBL] [Abstract][Full Text] [Related]
47. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
48. Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis.
Jin M; Fu X; Wei Y; Du B; Xu XT; Jiang WJ
Stroke; 2013 Nov; 44(11):2990-4. PubMed ID: 23963335
[TBL] [Abstract][Full Text] [Related]
49. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR;
JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors and therapeutic outcome of isolated symptomatic middle cerebral artery stenosis.
Tsai NW; Chang HW; Chang WN; Huang CR; Lin TK; Chen SD; Lui CC; Wang KW; Cheng BC; Hung PL; Chang CS; Lu CH
Eur J Neurol; 2005 Jul; 12(7):519-26. PubMed ID: 15958091
[TBL] [Abstract][Full Text] [Related]
51. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis.
Wong KS; Li H
Stroke; 2003 Oct; 34(10):2361-6. PubMed ID: 12947158
[TBL] [Abstract][Full Text] [Related]
52. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
Ringleb PA; Bhatt DL; Hirsch AT; Topol EJ; Hacke W;
Stroke; 2004 Feb; 35(2):528-32. PubMed ID: 14739421
[TBL] [Abstract][Full Text] [Related]
53. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study.
Miyasaka Y; Barnes ME; Gersh BJ; Cha SS; Seward JB; Bailey KR; Iwasaka T; Tsang TS
Stroke; 2005 Nov; 36(11):2362-6. PubMed ID: 16224079
[TBL] [Abstract][Full Text] [Related]
54. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators.
Benesch CG; Chimowitz MI
Neurology; 2000 Aug; 55(4):465-6. PubMed ID: 10953174
[No Abstract] [Full Text] [Related]
55. Impact of valvular thickness on stroke recurrence in medically treated patients with stroke.
Okajima K; Abe Y; Suzuki K; Salameh MJ; Di Tullio MR; Jin Z; Sacco RL; Mohr JP; Homma S;
Cerebrovasc Dis; 2007; 24(4):375-80. PubMed ID: 17804905
[TBL] [Abstract][Full Text] [Related]
56. Collaterals dramatically alter stroke risk in intracranial atherosclerosis.
Liebeskind DS; Cotsonis GA; Saver JL; Lynn MJ; Turan TN; Cloft HJ; Chimowitz MI;
Ann Neurol; 2011 Jun; 69(6):963-74. PubMed ID: 21437932
[TBL] [Abstract][Full Text] [Related]
57. The challenge of stroke prevention with intracranial arterial stenosis.
Turan TN; Smock A; Chimowitz MI
Curr Cardiol Rep; 2013 Dec; 15(12):422. PubMed ID: 24105641
[TBL] [Abstract][Full Text] [Related]
58. Current management of symptomatic intracranial stenosis: medical versus endovascular therapy.
Weigele JB; Taylor RA; Kasner SE
Curr Atheroscler Rep; 2007 Oct; 9(4):296-304. PubMed ID: 18173957
[TBL] [Abstract][Full Text] [Related]
59. Multiple intracranial arterial stenosis influences the long-term prognosis of symptomatic middle cerebral artery occlusion.
Tian L; Yue X; Xi G; Wang Y; Li Z; Zhou Y; Fan X
BMC Neurol; 2015 Apr; 15():68. PubMed ID: 25925171
[TBL] [Abstract][Full Text] [Related]
60. Risk Factors of Subacute Thrombosis After Intracranial Stenting for Symptomatic Intracranial Arterial Stenosis.
Sun X; Tong X; Lo WT; Mo D; Gao F; Ma N; Wang B; Miao Z
Stroke; 2017 Mar; 48(3):784-786. PubMed ID: 28130545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
